
### [NCIT:C3055](http://purl.obolibrary.org/obo/NCIT_C3055)
**Label:** Giant Cell Tumor

**Subclasses:** [NCIT:C121893](http://purl.obolibrary.org/obo/NCIT_C121893) (Giant Cell Lesion of Small Bones), [NCIT:C4304](http://purl.obolibrary.org/obo/NCIT_C4304) (Malignancy in Giant Cell Tumor of Bone), [NCIT:C27477](http://purl.obolibrary.org/obo/NCIT_C27477) (Benign Osteoclastic Giant Cell-Rich Tumor of Bone), [NCIT:C3402](http://purl.obolibrary.org/obo/NCIT_C3402) (Tenosynovial Giant Cell Tumor), [NCIT:C6535](http://purl.obolibrary.org/obo/NCIT_C6535) (Malignant Tenosynovial Giant Cell Tumor), [NCIT:C49107](http://purl.obolibrary.org/obo/NCIT_C49107) (Giant Cell Tumor of Soft Tissue), [NCIT:C121933](http://purl.obolibrary.org/obo/NCIT_C121933) (Malignant Osteoclastic Giant Cell-Rich Tumor of Bone), [NCIT:C6532](http://purl.obolibrary.org/obo/NCIT_C6532) (Tenosynovial Giant Cell Tumor, Localized Type), [NCIT:C121932](http://purl.obolibrary.org/obo/NCIT_C121932) (Giant Cell Tumor of Bone), [NCIT:C121931](http://purl.obolibrary.org/obo/NCIT_C121931) (Intermediate Osteoclastic Giant Cell-Rich Tumor of Bone), [NCIT:C3738](http://purl.obolibrary.org/obo/NCIT_C3738) (Osteoclastic Giant Cell-Rich Tumor of Bone), 

**Class expressions from DL-Learner:**

- [NCIT:C36843](http://purl.obolibrary.org/obo/NCIT_C36843) (Abnormal Connective and Soft Tissue Cell) 53.77%
- Thing 53.52%
- [NCIT:C12913](http://purl.obolibrary.org/obo/NCIT_C12913) (Abnormal Cell) 49.15%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) 39.52%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C3880](http://purl.obolibrary.org/obo/NCIT_C3880) (Eyelid Nevus))) 39.52%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C38784](http://purl.obolibrary.org/obo/NCIT_C38784) (Apoptosis Pathway))) 39.52%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C38770](http://purl.obolibrary.org/obo/NCIT_C38770) (Squamous Differentiation))) 39.52%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C38762](http://purl.obolibrary.org/obo/NCIT_C38762) (Thyroid Gland Mucoepidermoid Carcinoma))) 39.52%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C3876](http://purl.obolibrary.org/obo/NCIT_C3876) (Gastric Leiomyoma))) 39.52%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C38759](http://purl.obolibrary.org/obo/NCIT_C38759) (EBV Infection))) 39.52%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C38732](http://purl.obolibrary.org/obo/NCIT_C38732) (Defective Alpha Heavy Chain Present))) 39.52%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C38731](http://purl.obolibrary.org/obo/NCIT_C38731) (Villous Atrophy))) 39.52%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C38730](http://purl.obolibrary.org/obo/NCIT_C38730) (Lymphoepithelial Lesion))) 39.52%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C38727](http://purl.obolibrary.org/obo/NCIT_C38727) (Villous Lymphocyte))) 39.52%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C38721](http://purl.obolibrary.org/obo/NCIT_C38721) (Nuclear Pleomorphism))) 39.52%


